Research units on pediatric psychopharmacology autism network

Martin A, Scahill L, Anderson GM, Aman M, Arnold LE, McCracken J, McDougle CJ, Tierney E, Chuang S, Vitiello B (The Research Units on Pediatric Psychopharmacology Autism Network). Weight and lep-tin changes among risperidone-treated youths with autism 6-month prospective data. Am J Psychiatry 2004 161 1125-7. 

Research Units on Pediatric Psychopharmacology Autism Network. Risperidone treatment of autistic disorder longer-term benefits and blinded discontinuation after 6 months. Am J Psychiatry 2005 162 1361-9. 

Research Units on Pediatric Psychopharmacology Autism Network (2005a) Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62 1266-1274. 

Arnold, L.E., Aman, M.G., Martin, A., Collier-Crespin, A., Vitiello, B., Tierney, E. Asarnow, R., Bell-Bradshaw, F., Freeman, B.J., Gates-Ulanet, P., Klin, A., McCracken, J.T., McDougle, C.J., McGough, J.J., Posey, D.J., Scahill, L., Swiezy, N.B., Ritz, L., and Volkmar, F. (2000). Assessment in multisite randomized clinical trials of patients with autistic disorder the Autism RUPP Network. Research Units on Pediatric Psychopharmacology./Autism Dev Disord 30 99-111. 

B., Volkmar, F.R., Votolato, N.A., and Walson, P. (2000). Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. Child Adolesc Psychiatr Clin North Am 9 201-224. 

McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey Dl, Martin A, Ghuman IK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, HoUway 1, Koenig K, McGough JJ, Ritz L, Vitiello B (2005) Risperidone for the core symptom domains of autism results from the study by the autism network of the research units on pediatric psychopharmacology. Am 1 Psychiatry 162 1142-1148. 

---